CME Adds New Hemp Pricing Data12.17.2020
CME Group, the world’s leading and most diverse derivatives marketplace, announced that customers can now access hemp pricing data in DataMine, its self-service online data platform. This new alternative dataset from Hemp Benchmarks®, a division of New Leaf Data Services, LLC, allows CME Group market data customers to access benchmark wholesale hemp pricing data alongside nearly a petabyte of historical data for futures and options across every investible asset class.
“CME Group is continually exploring new ways to help our DataMine customers make the most informed trading decisions,” said Trey Berre, Global Head of Data Services at CME Group. “Market participants use our historical market data to test strategies, as well as gauge potential profitability and risks in a variety of different markets. As the U.S. hemp market continues to grow, we expect this benchmark hemp pricing data from Hemp Benchmarks® to aid our customers’ trading and hedging strategies.”
Access monthly pricing for more than 21 different types of industrial hemp products via CME DataMine, and get a comprehensive view of this emerging commodity.
— CME Group (@CMEGroup) December 15, 2020
“Hemp is an emerging commodity with a broad range of existing applications across wellness and health products, textiles, building materials and biofuels,” said Jonathan Rubin, CEO of Hemp Benchmarks®, a division of New Leaf Data Services, LLC. “Our industry-leading Hemp Benchmarks® data provides a comprehensive and transparent view of wholesale pricing, and we are pleased to be able to offer our data to CME Group’s market data customers around the world.”
Founded in 2015, New Leaf Data Services is the world’s first independent price reporting agency for global cannabis and hemp markets. The datasets available in CME DataMine include monthly pricing for more than 21 different types of hemp products, including Cannabidiol (CBD) Biomass, Crude Hemp Oil, CBD Distillates, CBD Isolate, and Cannabigerol (CBG) products.
Hemp is a variety of the Cannabis sativa plant that is grown for industrial use and to produce non-psychoactive cannabinoids such as CBD. In 2020, U.S. farmers registered nearly 400,000 acres for hemp cultivation. The U.S. hemp market is projected to grow to more than $20 billion in 2025.
For more information about accessing Hemp Benchmarks® pricing data in CME DataMine, please visit cmegroup.com/market-data/third-party-data-new-leaf.html.
Insight product aims to meet increased demand for information from institutional investors.
UK-based medicinal cannabis companies can be admitted to the Official List.
Vote to move the measure to the Senate can come any time.
This instrument is first backed by US cannabis companies.
The Swiss firm identified more than 30,000 securities linked to marijuana-related businesses.